A pharmacokinetic safety study to compare GTN blood plasma levels of MED2002 with existing cardiovascular GTN drugs
Phase of Trial: Phase I
Latest Information Update: 30 Mar 2017
At a glance
- Drugs Nitroglycerin (Primary)
- Indications Erectile dysfunction
- Focus Pharmacokinetics
- 30 Mar 2017 New trial record
- 23 Mar 2017 According to a Futura Medical media release, the company is consulting with the UK and US regulatory authorities to finalize design and timing of this study.
- 23 Mar 2017 According to a Futura Medical media release, the company expects completion of the trial in the fourth quarter of 2018 and regulatory submissions in the second quarter of 2019.